[go: up one dir, main page]

EP1711490A4 - P-GLYCOPROTEIN INHIBITOR, PREPARATION METHOD, AND PHARMACEUTICAL COMPOSITION COMPRISING THE SAME - Google Patents

P-GLYCOPROTEIN INHIBITOR, PREPARATION METHOD, AND PHARMACEUTICAL COMPOSITION COMPRISING THE SAME

Info

Publication number
EP1711490A4
EP1711490A4 EP04774781A EP04774781A EP1711490A4 EP 1711490 A4 EP1711490 A4 EP 1711490A4 EP 04774781 A EP04774781 A EP 04774781A EP 04774781 A EP04774781 A EP 04774781A EP 1711490 A4 EP1711490 A4 EP 1711490A4
Authority
EP
European Patent Office
Prior art keywords
preparation
same
pharmaceutical composition
glycoprotein inhibitor
glycoprotein
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP04774781A
Other languages
German (de)
French (fr)
Other versions
EP1711490A1 (en
Inventor
Mi Young Cha
Keuk Chan Bang
Young Gil Ahn
Maeng Sup Kim
Gwan Sun Lee
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Hanmi Pharmaceutical Co Ltd
Hanmi Pharmaceutical Industries Co Ltd
Original Assignee
Hanmi Pharmaceutical Co Ltd
Hanmi Pharmaceutical Industries Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hanmi Pharmaceutical Co Ltd, Hanmi Pharmaceutical Industries Co Ltd filed Critical Hanmi Pharmaceutical Co Ltd
Publication of EP1711490A1 publication Critical patent/EP1711490A1/en
Publication of EP1711490A4 publication Critical patent/EP1711490A4/en
Withdrawn legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
EP04774781A 2003-10-08 2004-10-07 P-GLYCOPROTEIN INHIBITOR, PREPARATION METHOD, AND PHARMACEUTICAL COMPOSITION COMPRISING THE SAME Withdrawn EP1711490A4 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
KR1020030069803A KR100580743B1 (en) 2003-10-08 2003-10-08 Novel chromone derivatives or pharmaceutically acceptable salts thereof having multi-drug resistance inhibitory activity and preparation methods thereof
PCT/KR2004/002557 WO2005033101A1 (en) 2003-10-08 2004-10-07 Novel p-glycoprotein inhibitor, method for the preparation thereof and pharmaceutical composition comprising the same

Publications (2)

Publication Number Publication Date
EP1711490A1 EP1711490A1 (en) 2006-10-18
EP1711490A4 true EP1711490A4 (en) 2007-04-04

Family

ID=36968286

Family Applications (1)

Application Number Title Priority Date Filing Date
EP04774781A Withdrawn EP1711490A4 (en) 2003-10-08 2004-10-07 P-GLYCOPROTEIN INHIBITOR, PREPARATION METHOD, AND PHARMACEUTICAL COMPOSITION COMPRISING THE SAME

Country Status (3)

Country Link
EP (1) EP1711490A4 (en)
KR (1) KR100580743B1 (en)
WO (1) WO2005033101A1 (en)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100557093B1 (en) 2003-10-07 2006-03-03 한미약품 주식회사 Tetrazole derivatives having multi-drug resistance inhibitory activity and preparation method thereof
KR100724125B1 (en) * 2005-02-24 2007-06-04 한국과학기술연구원 Chromone derivatives useful as calpine inhibitors and preparation methods thereof
KR100880163B1 (en) * 2007-05-30 2009-02-04 (주)바이오버드 Novel multidrug resistance inhibiting compounds and pharmaceutical compositions comprising the same
US11865093B2 (en) 2017-07-14 2024-01-09 University Of Massachusetts Methods and compositions for treating inflammation
EP4438618A3 (en) 2018-08-22 2025-01-01 Bacainn Biotherapeutics, Ltd. Cyclosporine compositions and methods of use
WO2020124070A1 (en) * 2018-12-14 2020-06-18 Athenex HK Innovative Limited Therapeutic combinations of orally administered irinotecan and a p-gp inhibitor for the treatment of cancer
CN111732567B (en) * 2020-06-17 2022-07-08 遵义医科大学 Chromone framework-containing polycyclic compound, and preparation method and application thereof
AU2021358977A1 (en) * 2020-10-07 2023-04-27 Health Hope Pharma Hk Limited Acetamido-phenylbenzamide derivatives and methods of using the same
CN117603219B (en) * 2023-11-29 2025-08-08 浙江大学 P-glycoprotein inhibitor and preparation method and application thereof

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6011069A (en) * 1995-12-26 2000-01-04 Nisshin Flour Milling Co., Ltd. Multidrug resistance inhibitors
GB9717576D0 (en) * 1997-08-19 1997-10-22 Xenova Ltd Pharmaceutical compounds
US6693099B2 (en) * 2000-10-17 2004-02-17 The Procter & Gamble Company Substituted piperazine compounds optionally containing a quinolyl moiety for treating multidrug resistance
KR100503161B1 (en) * 2002-07-18 2005-07-25 한미약품 주식회사 Novel p-glycoprotein inhibitor, method for preparing same and oral composition comprising same

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
No further relevant documents disclosed *

Also Published As

Publication number Publication date
KR20050034024A (en) 2005-04-14
WO2005033101A1 (en) 2005-04-14
KR100580743B1 (en) 2006-05-15
EP1711490A1 (en) 2006-10-18

Similar Documents

Publication Publication Date Title
EP1425019A4 (en) PHARMACEUTICAL COMPOSITION
IL170758A0 (en) 7-amino-isoindolyl compounds and their pharmaceutical uses
FI20011478A0 (en) Pharmaceutical composition
EE200300369A (en) Acylated indanylamines, process for their preparation, use and pharmaceutical preparation
IL165977A (en) Substituted pyrimidinylaminobenzamides , process for the preparation thereof and pharmaceutical compositions comprising the same
PL367180A1 (en) Durable pharmaceutical composition
RS20120139A3 (en) 8- [3-AMINO-PYRIDIN-1-IL] -XANTINE, THEIR PREPARATION AND THEIR APPLICATION AS PHARMACEUTICAL COMPOSITIONS
DK1575618T3 (en) Dispersible pharmaceutical combinations
PT102854A (en) BIOADESIVE MEDICINAL APPLICATION SYSTEM
DE60229819D1 (en) Powertrain and its assembly method
PL378135A1 (en) 2-cyanopyrrolopyrimidines and pharmaceutical uses thereof
EE200300416A (en) Pharmaceutical form
PT1467724E (en) AGOMELATIN ORODISPERSAVEL PHARMACEUTICAL COMPOSITION
DK1587478T3 (en) PHARMACEUTICAL COMPOSITION
EP1562618A4 (en) CYCLOOXYGENASE-2-INHIBITING WITHANOLIDAL COMPOSITIONS AND METHOD THEREOF
NO20035315D0 (en) Pharmaceutical combinations
PL394604A1 (en) Vinylazocycloalkanyl derivative, the use thereof and pharmaceutical composition
FI20022128L (en) Pharmaceutical composition
ITRM20030363A0 (en) COMPOSITIONS INCLUDING 3, 5DIIODOTYRONINE AND DIESSE PHARMACEUTICAL USE.
EP1711490A4 (en) P-GLYCOPROTEIN INHIBITOR, PREPARATION METHOD, AND PHARMACEUTICAL COMPOSITION COMPRISING THE SAME
DK1363490T3 (en) Agrochemicals
SI1590314T1 (en) 2-aryl-acetic acids, their derivatives and pharmaceutical compositions containing them
FI20031703A7 (en) Brake and method for adjusting the brake
EP1581258A4 (en) PHARMACEUTICAL FORMULATION AND METHOD OF MAKING THE SAME
FI20031065A0 (en) Insecticide, process for its preparation and its use

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20060814

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LI LU MC NL PL PT RO SE SI SK TR

DAX Request for extension of the european patent (deleted)
A4 Supplementary search report drawn up and despatched

Effective date: 20070301

REG Reference to a national code

Ref country code: HK

Ref legal event code: DE

Ref document number: 1093204

Country of ref document: HK

GRAP Despatch of communication of intention to grant a patent

Free format text: ORIGINAL CODE: EPIDOSNIGR1

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20100212

REG Reference to a national code

Ref country code: HK

Ref legal event code: WD

Ref document number: 1093204

Country of ref document: HK